1.
GM1 reduces injury-induced metabolic deficits and degeneration in the rat optic nerve.
Yoles E, Zalish M, Lavie V, Duvdevani R, Ben-Bassat S, Schwartz M
Invest Ophthalmol Vis SciDec 199231 citationsBasic Science
GM1 treatment for optic nerve crush injury in rats showed immediate metabolic benefits and a sevenfold increase in long-term axonal survival, suggesting its potential for treating optic nerve damage.